Jie Wang

Prof. Dr. Jie Wang

School of Pharmacy, Anhui Medical University, Hefei 230032, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
LLLizhi Liu
Lizhi Liu
DPDingyi Pan
Dingyi Pan
SCSheng Chen
Sheng Chen
MMMaria-Viola Martikainen
Maria-Viola Martikainen
Anna KårlundAnna Kårlund
Anna Kårlund
VLVesa-Pekka Lehto
Vesa-Pekka Lehto
Cell membrane (CM) coating technology is increasingly being applied in nanomedicine, but the entire coating procedure including adsorption, rupture, and fusion is not completely understood. Previously, we showed that the majority of biomimetic nanoparticles (NPs) were only partially coated, but the mechanism underlying this partial coating remains unclear, which hinders the further improvement of the coating technique. Here, we show that partial coating is an intermediate state due to the adsorption of CM fragments or CM vesicles, the latter of which could eventually be ruptured under external force. Such partial coating is difficult to self-repair to achieve full coating due to the limited membrane fluidity. Building on our understanding of the detailed coating process, we develop a general approach for fixing the partial CM coating: external phospholipid is introduced as a helper to increase CM fluidity, promoting the final fusion of lipid patches. The NPs coated with this approach have a high ratio of full coating (~23%) and exhibit enhanced tumor targeting ability in comparison to the NPs coated traditionally (full coating ratio of ~6%). Our results provide a mechanistic basis for fixing partial CM coating towards enhancing tumor accumulation.

28 October 2019 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
ZLZhi Li
Zhi Li
YHYuehua Hu
Yuehua Hu
QFQinrui Fu
Qinrui Fu
YLYang Liu
Yang Liu
Jie WangJie Wang
Jie Wang
Huanghao YangHuanghao Yang
Huanghao Yang

2 December 2019 in Nature Communications
Verified
Journal Article
Open access
XXXiaodong Xie
Xiaodong Xie
HNHuifang Nie
Huifang Nie
YZYu Zhou
Yu Zhou
SLShu Lian
Shu Lian
HMHao Mei
Hao Mei
LJLee Jia
Lee Jia
There are disease-causing biohazards in the blood that cannot be treated with modern medicines. Here we show that an intelligently designed safe biomaterial can precisely identify, tow and dump a targeted biohazard from the blood into the small intestine. Positively charged mesoporous silica nanoparticles (MSNs) functionalized with EGFR-targeting aptamers (MSN-AP) specifically recognize and bind blood-borne negatively charged oncogenic exosomes (A-Exo), and tow A-Exo across hepatobiliary layers and Oddi’s sphincter into the small intestine. MSN-AP specifically distinguish and bind A-Exo from interfering exosomes in cell culture and rat and patient blood to form MSN-AP and A-Exo conjugates (MSN-Exo) that transverse hepatocytes, cholangiocytes, and endothelial monolayers via endocytosis and exocytosis mechanisms, although Kupffer cells have been shown to engulf some MSN-Exo. Blood MSN-AP significantly decreased circulating A-Exo levels, sequentially increased intestinal A-Exo and attenuated A-Exo-induced lung metastasis in mice. This study opens an innovative avenue to relocate blood-borne life-threatening biohazards to the intestine.

17 January 2024 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
JWJunfeng Wang
Junfeng Wang
HJHan Jiang
Han Jiang
YCYuhong Chen
Yuhong Chen
XZXiaofan Zhu
Xiaofan Zhu
QWQian Wu
Qian Wu
PQPanzhu Qin
Panzhu Qin

1 October 2022 in Cancer Science
Verified
Journal Article
Open access
MWMENG WANG
MENG WANG
SLShijia Luan
Shijia Luan
XFXiang Fan
Xiang Fan
Jie WangJie Wang
Jie Wang
JHJu Huang
Ju Huang
DHdong han
dong han
For its various important functions in cells, phosphatase and tensin homolog‐induced kinase 1 (PINK1) has drawn considerable attention for the role it plays in early‐onset Parkinson's disease. In recent years, emerging evidence has supported the hypothesis that PINK1 plays a part in regulating many physiological and pathophysiological processes in cancer cells, including cytoplasmic homeostasis, cell survival, and cell death. According to the findings of these studies, PINK1 can function as a tumor promoter or suppressor, showing a duality that is dependent on the context. In this study we review the mechanistic characters relating to PINK1 based on available published data from peer‐reviewed articles, The Cancer Genome Atlas data mining, and cell‐based assays. This mini review focuses on some of the interplays between PINK1 and the context and recent developments in the field, including its growing involvement in mitophagy and its nonmitophagy organelles‐related function. This review aims to help readers better grasp how PINK1 is functioning in cell physiological and pathophysiological processes, especially in cancer biology.

1 December 2018 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
Jie WangJie Wang
Jie Wang
HDHai-Yan Dong
Hai-Yan Dong
YZYuyang Zhou
Yuyang Zhou
LHLong-Yu Han
Long-Yu Han
TZTing Zhang
Ting Zhang
LJLee Jia
Lee Jia